Edition:
United States

Cleveland Biolabs Inc (CBLI.OQ)

CBLI.OQ on NASDAQ Stock Exchange Capital Market

3.53USD
28 Apr 2017
Change (% chg)

$-0.07 (-1.94%)
Prev Close
$3.60
Open
$3.50
Day's High
$3.72
Day's Low
$3.43
Volume
88,974
Avg. Vol
158,232
52-wk High
$5.55
52-wk Low
$1.22

CBLI.OQ

Chart for CBLI.OQ

About

Cleveland BioLabs, Inc. (CBLI) is a biopharmaceutical company. The Company is engaged in developing approaches to activate the immune system and address serious medical needs. Its platform of Toll-like immune receptor activators has applications in mitigation of radiation injury and immuno-oncology. Its advanced product... (more)
No analyst recommendations are available for CBLI.OQ.

Overall

Beta: 0.83
Market Cap(Mil.): $39.66
Shares Outstanding(Mil.): 10.99
Dividend: --
Yield (%): --

Financials

  CBLI.OQ Industry Sector
P/E (TTM): -- 58.07 30.12
EPS (TTM): -0.24 -- --
ROI: -29.75 0.23 13.28
ROE: -30.54 6.18 14.44

BRIEF-Cleveland Biolabs announces European Medicines Agency positive opinion regarding entolimod pediatric investigation plan

* Cleveland Biolabs announces European Medicines Agency positive opinion regarding the entolimod pediatric investigation plan

Apr 17 2017

BRIEF-Cleveland Biolabs announces commencement of in Vivo Biocomparability study

* Cleveland Biolabs announces commencement of in Vivo biocomparability study

Apr 17 2017

BRIEF-Cleveland Biolabs reports Q4 loss per share $0.11

* Cleveland Biolabs reports 2016 financial results and development progress

Feb 22 2017

More From Around the Web

Earnings vs. Estimates